News from us and our partners

Tags

Topics

0 results

News
9 July, 2024
Afyren's fermentation lab reaches 2-million-hour-mark as it identifies new raw materials to fuel industrial expansion
News
9 July, 2024
Endoron Medical raises $10 Million in Series A funding led by Sofinnova Partners to accelerate the validation of its AAA EndoStapling solution Aortoseal
News
8 July, 2024
Myricx Bio announces £90m ($114m) Series A financing to advance its novel NMTi-ADC therapeutics into clinical development
News
5 July, 2024
Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position
News
2 July, 2024
Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325
News
2 July, 2024
Sitryx announces leadership transition
News
28 June, 2024
Redx Reports encouraging Zamaporvint (RXC004) Phase 2 combination data in MSS mCRC at ESMO GI Congress supporting genetic selection hypothesis in hard-to-treat GI Cancers
News
27 June, 2024
Chroma Medicine announces exclusive license agreement with the Whitehead Institute for Novel Epigenetic Editing Technology
News
27 June, 2024
Sensorion appoints Laurene Danon as CFO
News
26 June, 2024
Crescendo Biologics announces that Zai Lab has initiated a global Phase 2 clinical trial evaluating ZL-1102 (Humabody®, CB001) as a topical treatment for psoriasis
News
18 June, 2024
BrightHeart appoints Michael Butchko as Chairman of the Board
News
17 June, 2024
Meiogenix hires Ricardo Garcia de Alba as CEO
News
12 June, 2024
NodThera meets primary endpoint in Phase 1b/2a trial
News
12 June, 2024
T-Therapeutics appoints Dr. David Hung as Chairman
News
12 June, 2024
Danone, DMC, Michelin and Crédit Agricole Centre France join forces to create a cutting-edge biotechnology platform
News
7 June, 2024
SafeHeal's Colovac wins FDA Breakthrough Device designation

Afyren's fermentation lab reaches 2-million-hour-mark as it identifies new raw materials to fuel industrial expansion

Endoron Medical raises $10 Million in Series A funding led by Sofinnova Partners to accelerate the validation of its AAA EndoStapling solution Aortoseal

Myricx Bio announces £90m ($114m) Series A financing to advance its novel NMTi-ADC therapeutics into clinical development

Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position

Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325

Sitryx announces leadership transition

Redx Reports encouraging Zamaporvint (RXC004) Phase 2 combination data in MSS mCRC at ESMO GI Congress supporting genetic selection hypothesis in hard-to-treat GI Cancers

Chroma Medicine announces exclusive license agreement with the Whitehead Institute for Novel Epigenetic Editing Technology

Sensorion appoints Laurene Danon as CFO

Crescendo Biologics announces that Zai Lab has initiated a global Phase 2 clinical trial evaluating ZL-1102 (Humabody®, CB001) as a topical treatment for psoriasis

BrightHeart appoints Michael Butchko as Chairman of the Board

Meiogenix hires Ricardo Garcia de Alba as CEO

NodThera meets primary endpoint in Phase 1b/2a trial

T-Therapeutics appoints Dr. David Hung as Chairman

Danone, DMC, Michelin and Crédit Agricole Centre France join forces to create a cutting-edge biotechnology platform

SafeHeal's Colovac wins FDA Breakthrough Device designation